Found 6 matching trials
The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
PHASE4IPE-PREVENTION is a prospective, randomized, 3-month long, open-label study...
Location
The Oshawa Clinic
Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.
NACardiovascular diseases (CVDs) are the leading cause of global mortality, d...
Location
Multiple Locations
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
PHASE4This randomized controlled study will evaluate whether icosapent ethyl (IPE...
Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling
N/AEven with standard treatments like statins, patients with coronary artery d...
Location
Multiple Locations
PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial
PHASE3The PREPARE-IT investigator-initiated trial program is a simple, pragmatic,...
Location
Instituto de Investigaciones Clínicas - Rosario
Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid
PHASE2The number of Americans diagnosed with Alzheimer's disease (AD) is expected...
Location
William S. Middleton Memorial Veterans Hospital, Madison, WI